Celcuity Inc. Schedules Release of Third Quarter Fiscal 2017 Financial Results and Conference Call

MINNEAPOLIS--()--Celcuity Inc. (NASDAQ: CELC) a functional cellular analysis company that is discovering new cancer subtypes and commercializing diagnostic tests designed to significantly improve clinical outcomes of cancer patients treated with targeted therapies, announced that it will release its financial results for the third quarter of fiscal 2017 before the opening of the stock market on Monday, November 13, 2017. Management will host a teleconference the same day at 4:30 p.m. Eastern Time (ET) to discuss the results.

Conference Call Details
Participants should dial 1-800-459-5346 referencing confirmation code “Celcuity” (23528489). Participants are asked to dial in 5 to 10 minutes prior to the start of the call and inform the operator you would like to join the “Celcuity Conference Call.”

About Celcuity
We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform uses a patient’s living tumor cells to identify the specific abnormal cellular activity driving a patient’s cancer and the targeted therapy that can best treat that patient’s disease. Celcuity is headquartered in Minneapolis, MN. Further information about Celcuity can be found at www.celcuity.com.

Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including the anticipated benefits to the clinical outcomes of cancer patients. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of Celcuity, which include, but are not limited to, those set forth in the Risk Factors section of Celcuity’s Prospectus, dated September 19, 2017, filed with the Securities and Exchange Commission on September 20, 2017 pursuant to Rule 424(b)(4) under the Securities Act of 1933, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Celcuity undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts

Celcuity Inc.
Brian Sullivan
bsullivan@celcuity.com
or
Vicky Hahne
vhahne@celcuity.com

Contacts

Celcuity Inc.
Brian Sullivan
bsullivan@celcuity.com
or
Vicky Hahne
vhahne@celcuity.com